"Rheumatic Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement.
Descriptor ID |
D012216
|
MeSH Number(s) |
C05.799 C17.300.775
|
Concept/Terms |
Rheumatic Diseases- Rheumatic Diseases
- Disease, Rheumatic
- Diseases, Rheumatic
- Rheumatic Disease
- Rheumatism
|
Below are MeSH descriptors whose meaning is more general than "Rheumatic Diseases".
Below are MeSH descriptors whose meaning is more specific than "Rheumatic Diseases".
This graph shows the total number of publications written about "Rheumatic Diseases" by people in this website by year, and whether "Rheumatic Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 1 | 0 | 1 |
2005 | 1 | 1 | 2 |
2007 | 1 | 1 | 2 |
2011 | 2 | 0 | 2 |
2012 | 0 | 1 | 1 |
2013 | 3 | 0 | 3 |
2014 | 3 | 0 | 3 |
2015 | 0 | 1 | 1 |
2016 | 1 | 0 | 1 |
2017 | 44 | 6 | 50 |
2018 | 45 | 8 | 53 |
2019 | 15 | 3 | 18 |
2020 | 75 | 4 | 79 |
2021 | 59 | 5 | 64 |
2022 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Rheumatic Diseases" by people in Profiles.
-
COVID-19 in Patients With Rheumatic Diseases: Is There a Need to Worry? J Clin Rheumatol. 2022 03 01; 28(2):e401-e406.
-
Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two-Dose SARS-CoV-2 Messenger RNA Vaccination. Arthritis Rheumatol. 2022 01; 74(1):28-32.
-
Suggested Considerations for the Treatment of Rheumatic Diseases in Adult Patients With COVID-19: Comment on the Article by Mikuls et al. Arthritis Rheumatol. 2021 12; 73(12):2355.
-
Cluster analysis reveals three main patterns of beliefs and intention with respect to SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseases. Rheumatology (Oxford). 2021 10 09; 60(SI):SI68-SI76.
-
Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy. Rheumatology (Oxford). 2021 10 09; 60(SI):SI25-SI36.
-
Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series. Rheumatology (Oxford). 2021 10 09; 60(SI):SI90-SI95.
-
The influence of the SARS-CoV-2 lockdown on patients with inflammatory rheumatic diseases on their adherence to immunomodulatory medication: a cross sectional study over 3 months in Germany. Rheumatology (Oxford). 2021 10 09; 60(SI):SI51-SI58.
-
The impact of the COVID-19 pandemic on people with rheumatic and musculoskeletal diseases: insights from patient-generated data on social media. Rheumatology (Oxford). 2021 10 09; 60(SI):SI77-SI84.
-
Editorial: Rheumatology at the center of coronavirus disease 2019: pathogenesis, treatment, and clinical care. Curr Opin Rheumatol. 2021 09 01; 33(5):409-411.
-
Coronavirus disease 2019: update on coronavirus disease 2019 outcomes and vaccine efficacy in patients with immune-mediated inflammatory disease. Curr Opin Rheumatol. 2021 09 01; 33(5):412-418.